Larry Midyett, MD
Pediatric Endocrinology · Overland Park, KSNPI 1174555957
Payments from drug & device makers
Across 517 payments — averaging $406.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$195K
- Tandem Diabetes Care, Inc.$10K
- Pfizer$1K
- AbbVie$860
- Novo Nordisk$646
- Lilly USA, LLC$469
- plus $2K from 24 others
What the payments were for
- Consulting fees$117,65056%
- Speaking & faculty fees$66,04531%
- Travel & lodging$13,2006%
- Food & beverage$13,0316%
- Education$2000%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 240 | $195,394 |
| Tandem Diabetes Care, Inc. | 24 | $9,559 |
| Pfizer | 20 | $1,064 |
| AbbVie | 54 | $860 |
| Novo Nordisk | 41 | $646 |
| Lilly USA, LLC | 24 | $469 |
| Insulet Corporation | 17 | $283 |
| Dexcom, Inc. | 13 | $270 |
| Mannkind Corporation | 10 | $202 |
| Antares Pharma, Inc. | 11 | $200 |
| Tolmar, Inc. | 7 | $163 |
| Sanofi-aventis U.S. LLC | 8 | $124 |
| Ipsen Biopharmaceuticals, Inc | 5 | $116 |
| Corcept Therapeutics | 5 | $97 |
| Ascendis Pharma Endocrinology Inc | 4 | $81 |
| Endo Pharmaceuticals Inc. | 4 | $70 |
| Ferring Pharmaceuticals Inc. | 5 | $69 |
| Cequr Corporation | 2 | $67 |
| Xeris Pharmaceuticals, Inc. | 4 | $63 |
| Tolmar Pharmaceuticals, Inc. | 3 | $58 |
| Regeneron Healthcare Solutions, Inc. | 3 | $55 |
| Medtronic(2 entities) | 3 | $38 |
| IBSA Pharma Inc. | 2 | $34 |
| Azurity Pharmaceuticals, Inc. | 2 | $29 |
| Ultragenyx Pharmaceutical Inc. | 1 | $23 |
| Amphastar Pharmaceuticals, Inc. | 1 | $20 |
| Endo USA, Inc. | 1 | $20 |
| Arbor Pharmaceuticals, Inc. | 1 | $19 |
| Amgen | 1 | $18 |
| Aegerion Pharmaceuticals, Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- FREESTYLE LIBRE 3$96,055
- FreeStyle Libre Pro$56,131
- FreeStyle Libre$29,777
- t:slim X2 Insulin Pump with Control-IQ$9,244
How this compares
Too few pediatric endocrinology providers in Kansasto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 108 | $152,810 |
| Omnipod 5 Dexg7g6 Pods (Gen 5)Insulin Pump Cart,auto,bt,g6/7 | 85 | $147,992 |
| GenotropinSomatropin | 33 | $126,604 |
| TrulicityDulaglutide | 66 | $84,419 |
| MounjaroTirzepatide | 53 | $82,011 |
| JardianceEmpagliflozin | 65 | $58,402 |
| Tresiba Flextouch U-200Insulin Degludec | 20 | $34,174 |
| Humulin R U-500Insulin Regular, Human | 22 | $32,361 |
| Tresiba Flextouch U-100Insulin Degludec | 29 | $24,778 |
| Solu-CortefHydrocortisone Sodium Succ/Pf | 38 | $21,725 |
| FiaspInsulin Aspart (Niacinamide) | 12 | $13,742 |
| Omnipod Dash Pods (Gen 4)Insulin Pump Cart,cont Inf,bt | 13 | $13,667 |
| Fiasp FlextouchInsulin Aspart (Niacinamide) | 20 | $12,625 |
| FarxigaDapagliflozin Propanediol | 11 | $12,268 |
| HumalogInsulin Lispro | 31 | $9,604 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCTrulicity, Mounjaro, Humalog | $469 | $176,034150 claims |
| Novo NordiskOzempic, Fiasp, Novolog | $646 | $172,775144 claims |
| PfizerGenotropin | $1,064 | $126,60433 claims |
| Cequr CorporationCequr Simplicity | $67 | $6,04912 claims |
| IBSA Pharma Inc.Tirosint-Sol | $34 | $5,80718 claims |
| AbbVieSynthroid, Armour Thyroid | $860 | $4,70739 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. There are too few pediatric endocrinology providers in Kansason file to place this against a meaningful peer group, so we don't.
Other pediatric endocrinology in Overland Park
- Patria Alba AponteTopeka$4K
- Katie BargerTopeka$2K
- Jacob RedelTopeka$2K
- Shilpi RelanWichita$2K
- James CaseyTopeka$1K
- Fadi Al MuhaisenWichita$612
- Christopher BlueWichita$465
- Katarina GambosovaLawrence$435
- Lina SaadehWichita$303
- Tiffany MusickTopeka$228
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.